Navigation Links
FDLI's Food and Drug Policy Forum Examines European GMO Rules

WASHINGTON, Jan. 25, 2011 /PRNewswire-USNewswire/ -- The second issue of FDLI's Food and Drug Policy Forum (Volume 1, Number 2), to be published January 26, 2011, focuses on the increasingly important issue of genetically modified organisms (GMOs).

In the article published on the Food and Drug Law Institute's website (, Ross H. Pifer, Director, and Richard J. Lupinsky, Jr., Research Fellow at the Agricultural Law Resource and Reference Center at Penn State University's Dickinson School of Law, make recommendations on this emerging international food and drug issue: "Should the European Union Proceed with the Implementation of New GMO Rules?"

Pifer and Lupinsky conclude that new GMO rules in the European Union need additional clarity to create a proper framework for the approval of genetically modified products, explaining that "stakeholders on all sides believe that the proposal actually will increase legal uncertainty and create more chaos surrounding both the decision-making process and labeling standards." The authors specifically recommend that the European Commission modify the major standard expressed in proposed Article 26b(a), a European Union Member States' Directive, to better explain the specific bases upon which Member States can restrict or prohibit cultivation of particular GMOs, integrate and harmonize the content of Article 26b with the Safeguard Clause, and maintain uniform standards of labeling for GMOs.

FDLI's Food and Drug Policy Forum is a twice-a-month, peer-reviewed, digital publication on current food and drug policy topics. Posed in the form of a question, each issue provides subscribers and purchasers with pertinent background information, relevant research, a discussion of central issues, relevant resources and policy recommendations. The views, opinions and statements expressed in the Policy Forum are those of the authors. The Food and Drug Law Institute neither contributes to nor endorses Policy Forum articles. As a nonprofit 501 (c) (3) organization, FDLI does not engage in advocacy activities.

FDLI, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. FDLI's scope includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

FDLI members receive the Policy Forum as a benefit of their membership. Non-members may subscribe to the Forum for a fee.

SOURCE Food and Drug Law Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Change in Medicare Wheelchair Policy May Prevent Texas Beneficiaries from Receiving Mobility Assistance Starting January
2. Rural Wheelchair Patients Will Be Hit Hard by Power Wheelchair Rental Policy; Providers, Advocates Ask Congress for a Delay
3. K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSEs Shareholder Approval Policy
4. Congress Urged to Delay New Medicare Wheelchair Rental Policy
5. Medicare Policy Changes Will Make it More Difficult for Nevada Beneficiaries to Obtain Power Wheelchairs
6. Utahs Seniors and People with Disabilities Will Feel Impact of Medicare Policy Changes that Restrict Access to Power Wheelchairs
7. American College of Surgeons Health Policy Research Institute Releases Surgery Workforce Atlas That Shows Surgeon Shortage Across the U.S.
8. Physician Outraged by Medicare Power Wheelchair Documentation Policy
9. NORD Calls for Statement of Policy on Orphan Drug Development
10. Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities
11. Stryker Modifies Its Dividend Policy and Declares Transition Dividend
Post Your Comments:
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... N.J. , June 23, 2016  Guerbet announced ... Premier Inc.,s Supplier Horizon Award . ... year, Guerbet was recognized for its support of Premier ... creation through clinical excellence, and commitment to lower costs. ... to receive this recognition of our outstanding customer service ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
Breaking Medicine News(10 mins):